A detailed history of Alkeon Capital Management LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Alkeon Capital Management LLC holds 2,345,361 shares of PMVP stock, worth $3.87 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,345,361
Previous 2,345,361 -0.0%
Holding current value
$3.87 Million
Previous $3.99 Million 4.72%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$1.23 - $6.6 $2,525 - $13,549
-2,053 Reduced 0.09%
2,345,361 $7.27 Million
Q3 2023

Nov 13, 2023

BUY
$6.01 - $8.93 $5.21 Million - $7.75 Million
867,547 Added 58.62%
2,347,414 $14.4 Million
Q2 2023

Aug 11, 2023

BUY
$3.94 - $6.27 $388,239 - $617,833
98,538 Added 7.13%
1,479,867 $9.26 Million
Q1 2023

May 12, 2023

SELL
$4.77 - $9.16 $18,784 - $36,072
-3,938 Reduced 0.28%
1,381,329 $6.59 Million
Q4 2022

Feb 13, 2023

SELL
$8.17 - $12.95 $1.08 Million - $1.71 Million
-131,979 Reduced 8.7%
1,385,267 $12.1 Million
Q3 2022

Nov 10, 2022

SELL
$11.4 - $17.18 $30,654 - $46,197
-2,689 Reduced 0.18%
1,517,246 $18.1 Million
Q2 2022

Aug 15, 2022

SELL
$9.23 - $22.43 $734,874 - $1.79 Million
-79,618 Reduced 4.98%
1,519,935 $21.7 Million
Q4 2021

Feb 14, 2022

BUY
$19.99 - $30.24 $3.6 Million - $5.44 Million
180,000 Added 12.68%
1,599,553 $36.9 Million
Q3 2021

Nov 15, 2021

BUY
$26.84 - $36.58 $7.84 Million - $10.7 Million
292,135 Added 25.91%
1,419,553 $42.3 Million
Q2 2021

Aug 16, 2021

SELL
$28.01 - $36.01 $63,386 - $81,490
-2,263 Reduced 0.2%
1,127,418 $38.5 Million
Q1 2021

May 17, 2021

BUY
$30.66 - $49.5 $77,569 - $125,235
2,530 Added 0.22%
1,129,681 $37.2 Million
Q4 2020

Feb 16, 2021

BUY
$31.86 - $61.51 $20.8 Million - $40.1 Million
652,151 Added 137.29%
1,127,151 $69.3 Million
Q3 2020

Nov 16, 2020

BUY
$35.5 - $38.0 $16.9 Million - $18.1 Million
475,000 New
475,000 $16.9 Million

Others Institutions Holding PMVP

About PMV Pharmaceuticals, Inc.


  • Ticker PMVP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,622,600
  • Market Cap $75.3M
  • Description
  • PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...
More about PMVP
Track This Portfolio

Track Alkeon Capital Management LLC Portfolio

Follow Alkeon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alkeon Capital Management LLC with notifications on news.